A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy-Reference-Cited by-同舟云学术

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

Published:2018-10-04 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

De Mattia Elena,Dreussi Eva,Montico Marcella,Gagno Sara,Zanusso Chiara,Quartuccio Luca,De Vita Salvatore,Guardascione Michela,Buonadonna Angela,D’Andrea Mario,Pella Nicoletta,Favaretto Adolfo,Mini Enrico,Nobili Stefania,Romanato Loredana,Cecchin Erika,Toffoli Giuseppe

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference57 articles.

1. Apoptosis of colorectal adenocarcinoma induced by 5-FU and/or IFN-gamma through caspase 3 and caspase 8.;Adachi;Int. J. Oncol.,1999

2. Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies.;Apetoh;Curr. Mol. Med.,2011

3. Immunotherapy in colorectal cancer: for the select few or all?;Arora;J. Gastrointest. Oncol.,2018

4. Controlling the false discovery rate: a practical and powerful approach to multiple testing.;Benjamini;J. R. Stat. Soc. Ser. B,1995

5. A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.;Cecchin;Pharmacogenomics J.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm;Cancers;2021-04-03

2. Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy;Radiotherapy and Oncology;2020-08

3. Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy;Frontiers in Pharmacology;2020-06-17

4. A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer;Gynecologic Oncology;2020-01

5. The use of pharmacogenetics to increase the safety of colorectal cancer patients treatedwith fluoropyrimidines;Cancer Drug Resistance;2019